US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
GeoVax Labs Inc (GOVX)
GeoVax Labs Inc (GOVX) ニュース

GOVX

GeoVax Labs (GOVX)

GeoVax Labs Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GOVX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/05	01 : 30	GlobeNewswire Inc.	GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine	NASDAQ:GOVX	GeoVax Labs Inc
2024/03/28	22 : 00	GlobeNewswire Inc.	GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress	NASDAQ:GOVX	GeoVax Labs Inc
2024/03/12	22 : 00	GlobeNewswire Inc.	GeoVax to Present at the 36th Annual Roth Conference	NASDAQ:GOVX	GeoVax Labs Inc
2024/03/12	05 : 13	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:GOVX	GeoVax Labs Inc
2024/03/11	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:GOVX	GeoVax Labs Inc
2024/03/11	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:GOVX	GeoVax Labs Inc
2024/03/11	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:GOVX	GeoVax Labs Inc
2024/03/11	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:GOVX	GeoVax Labs Inc
2024/03/06	23 : 00	GlobeNewswire Inc.	GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System	NASDAQ:GOVX	GeoVax Labs Inc
2024/03/02	06 : 08	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:GOVX	GeoVax Labs Inc
2024/03/01	06 : 05	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:GOVX	GeoVax Labs Inc
2024/03/01	06 : 00	GlobeNewswire Inc.	GeoVax Reports 2023 Year-End Financial Results and Provides Business Update	NASDAQ:GOVX	GeoVax Labs Inc
2024/02/23	06 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GOVX	GeoVax Labs Inc
2024/02/22	23 : 00	GlobeNewswire Inc.	GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024	NASDAQ:GOVX	GeoVax Labs Inc
2024/02/19	23 : 00	GlobeNewswire Inc.	GeoVax to Present at the 2024 BIO CEO & Investor Conference	NASDAQ:GOVX	GeoVax Labs Inc
2024/02/17	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOVX	GeoVax Labs Inc
2024/02/15	05 : 38	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:GOVX	GeoVax Labs Inc
2024/02/13	23 : 00	GlobeNewswire Inc.	GeoVax Announces Multiple Patent Issuances and Allowances	NASDAQ:GOVX	GeoVax Labs Inc
2024/02/08	06 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GOVX	GeoVax Labs Inc
2024/02/06	23 : 00	GlobeNewswire Inc.	GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster	NASDAQ:GOVX	GeoVax Labs Inc
2024/02/01	03 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOVX	GeoVax Labs Inc
2024/01/29	23 : 00	GlobeNewswire Inc.	GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement	NASDAQ:GOVX	GeoVax Labs Inc
2024/01/17	06 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOVX	GeoVax Labs Inc
2024/01/13	06 : 00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:GOVX	GeoVax Labs Inc
2024/01/12	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:GOVX	GeoVax Labs Inc
2024/01/08	23 : 00	GlobeNewswire Inc.	GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology	NASDAQ:GOVX	GeoVax Labs Inc
2024/01/04	23 : 00	GlobeNewswire Inc.	GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients	NASDAQ:GOVX	GeoVax Labs Inc
2024/01/03	23 : 00	GlobeNewswire Inc.	GeoVax Announces Issuance of Malaria Vaccine Patent	NASDAQ:GOVX	GeoVax Labs Inc
2024/01/03	06 : 10	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:GOVX	GeoVax Labs Inc
2023/12/27	23 : 00	GlobeNewswire Inc.	GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024	NASDAQ:GOVX	GeoVax Labs Inc

Showing the most relevant articles for your search:NASDAQ:GOVX

1 2 3 4 5 6 7 8 9 10 次へ >>

Ayr Wellness (QX)

Universe Pharmaceuticals

Atlas Financial (CE)

BBASI445 Ex:21,72

Western Asset Inflation ...

BPCE Maturity dt 08jun2027

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約